Transformative Science Coupled With A Unique KojoX™ Operational Ecosystem: The Keys to Achieving Unparalleled Flexibility In CHO Based Bioproduction
By Leon Pybus Ph.D., Associate Director of Cell Culture Process Development, FUJIFILM Biotechnologies

The bioprocessing industry faces a major challenge: keeping up with the rising global demand for medicine. With new monoclonal antibodies, cell therapies, and gene therapies developing so quickly, we need innovative manufacturing methods to achieve the necessary scale, speed, and sustainability.
FUJIFILM Biotechnologies is transforming the industry with our globally unified system, kojoX™. This unique operational ecosystem gives our partners flexibility and unmatched speed to market. We're also pioneering new science through partnerships with top universities and our Bioscience and Engineering Laboratory (BSEL) near Tokyo. Our ultimate goal is to make life-changing therapies more accessible and affordable for everyone.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.